Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2009-2-17
pubmed:abstractText
Clostridium septicum alpha-toxin is a beta-barrel pore-forming cytolysin that is functionally similar to aerolysin. Residues important in receptor binding, oligomerization, and pore formation have been identified; however, little is known about the activity of the toxin in an infection, although it is essential for disease. We have now shown that deletion of a small portion of the transmembrane domain, so that the toxin is no longer able to form pores, completely abrogates its ability to contribute to disease, as does replacement of the sole cysteine residue with leucine. However, although previous biochemical and cytotoxicity assays clearly indicated that mutations in residues important in oligomerization, binding, and prepore conversion greatly reduced activity or rendered the toxin inactive, once the mutated toxins were overexpressed by the natural host in the context of an infection it was found they were able to cause disease in a mouse model of myonecrosis. These results highlight the importance of testing the activity of virulence determinants in the normal host background and in an infectious disease context and provide unequivocal evidence that it is the ability of alpha-toxin to form a pore that confers its toxicity in vivo.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-10048023, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-10456947, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-10480947, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-10508864, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-10722564, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-11152463, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-11705975, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-11736823, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-12117945, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-12356721, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-12406220, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-12745042, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-13598715, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-1450366, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-14715670, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-1513878, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-15258571, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-1541552, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-15619423, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-15699597, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-16041001, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-16102005, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-16239541, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-16337096, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-16520379, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-16567392, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-17128973, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-17234446, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-17720603, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-17989920, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-1965218, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-2642585, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-7570310, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-7638902, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-7680572, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-7746141, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-7806374, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-7968539, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-8200504, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-9044288, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-9302006, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-9514706, http://linkedlifedata.com/resource/pubmed/commentcorrection/19139192-9615432
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1098-5522
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
77
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
943-51
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Pore-forming activity of alpha-toxin is essential for clostridium septicum-mediated myonecrosis.
pubmed:affiliation
Department of Microbiology, Monash University, Clayton, Victoria, Australia.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural